Dr. Andrew C. Hoover, MD

Dr. Hoover practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Hoover's NPI, 1831418276, was assigned on May 25, 2010. Dr. Hoover graduated from University of Iowa, RJ & L Carver College of Medicine in 2010. Dr. Hoover holds Kansas license 0438096.

Dr. Hoover's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Hoover's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Hoover is also affiliated with The University of Kansas Health System St. Francis Campus. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Hoover to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hoover practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Hoover's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Hoover's licenses on file in 2 states: Kansas and Iowa.

CMS data shows 1,581 Medicare services from Dr. Hoover across 17 procedure codes in 2024, for 333 Medicare patients. Medicare paid $103,330 for them.

CMS counts 333 Medicare patients who saw Dr. Hoover in 2024. The largest group is 65 to 74, with 188 patients. 75% of them have high blood pressure, and 73% have cancer. 6% are also on Medicaid. Their average risk score is 1.79, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hoover's median patient age at 71, with 73% women.

In 2024, Dr. Hoover wrote 44 Medicare Part D claims for 21 patients. 98% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $136 in total drug cost. In 2020, CMS named 15 claims across 1 drug.

Dr. Hoover accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hoover as offering telehealth.

Dmand AI links 11 papers to Dr. Hoover, published from 2014 to 2023. 2019 was the busiest year, with 3. The most frequent topics are Tomography, X-Ray Computed, Genital Neoplasms, Female and Head and Neck Neoplasms. Dr. Hoover has published most often in J Med Imaging Radiat Oncol. Dr. Hoover's most frequent co-authors are Carryn M. Anderson, MD, Rohit Gunan Ganju, MD and Allen M. Chen, MD.

Dmand AI links Dr. Hoover to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Rectal Neoplasms, Vaginal Neoplasms and Rectal Diseases.

CMS Open Payments shows 1 general payment to Dr. Hoover from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. BTG International, Inc. paid the most, $40.

Dr. Hoover graduated from University of Iowa, RJ & L Carver College of Medicine in 2010.